CoQ10
|
Coenzyme Q10
|
ADI |
Acceptable daily intake |
NOAEL |
No-observed-adverse-effect level |
UVB |
Ultraviolet B |
CVD |
Diabetic cardiovascular disease |
ROS |
Reactive oxygen species |
RAGE |
Receptor for advanced glycation end products |
AGEs |
Advanced glycation end products |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
PKC |
Protein kinase C |
DN |
Diabetic nephropathy |
UTMD |
Ultrasound-targeted microbubble destruction |
MSA |
Multiple system atrophy |
CSF |
Cerebrospinal fluid |
COQ2 |
Coenzyme Q2 |
COQ9 |
Coenzyme Q9 |
COQ8A |
Coenzyme Q8A |
ETFDH |
Electron transfer flavoprotein dehydrogenase |
PDSS2 |
Decaprenyl diphosphate synthase subunit 2 |
AIDS |
Acquired immune deficiency syndrome |
CRP |
C-reactive protein |
IL-6 |
Interleukin 6 |
TNF-α |
Tumor necrosis factor alpha |
P-gp |
P-glycoprotein |
TPGS |
α-tocopherol polyethylene glycol 1000 succinate |
RGC |
Retinal ganglion cells |
IOP |
Intraocular pressure |
PD |
Parkinson disease |
NF-β |
Nuclear factor beta |
POPC |
Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine |
IMM |
Inner mitochondrial membrane |
IIF |
Flavin site in complex II |
FM |
Fibromyalgia |
IL-1β |
Interleukin 1 beta |
UV |
Ultraviolet |
IL-18 |
Interleukin 18 |
FH |
Familial hypercholesterolemia |
GIT |
Gastrointestinal tract |
SNEDDS |
Self-nanoemulsifying drug delivery systems |
HPH |
High-pressure homogenization |
PHCO |
PEG40 hydrogenated castor oil |
TPGS |
Tocopherol polyethylene glycol succinate |
EC |
Ethyl cellulose |
MCT |
Medium-chain triglyceride |
SMS |
SMS detergent |
CMC |
Critical micelle concentration |
HMGCR |
3-hydroxy-3-methyl-glutaryl-coenzyme A reductase |
LDL |
Low-density lipoprotein |
LDL-R |
Low-density lipoprotein receptor |
ACE |
Angiotensin-converting enzyme |
CHF |
Chronic heart failure |